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Background
Past studies have suggested that certain portions of the
integrated HIV-1 proviral genome can be transcribed in
the anti-sense direction, resulting in novel viral protein
products that may provide alternative targets for the host
anti-viral immune response. Little is known whether
immune responses exist against antisense HIV peptides,
whether they can recognize HIV infected cells and
whether CTL-driven escape mutations within antisense
peptides may be detectable on a population level.
Methods
Anti-sense sequences with potential start codons (Methio-
nine) that preceded well-conserved genome sequences of
at least 50 nucleotide triplets without stop codon were
identified in 261 aligned HIV whole-genome sequences.
Plasma HIV gag, pol and nef sequences from >500 treat-
ment-naive, chronic infected patients were analyzed for
HLA class I allele-specific viral polymorphisms in all three
possible reading frames in the anti-sense direction. A max-
imal false-discovery rate of 20% (q value < 0.2) was
applied to correct for multiple tests. Polymorphisms in
the anti-sense direction that affected the original coding
sequence were excluded from study.
Results
Five potential anti-sense encoded proteins, including the
previously described HIV anti-sense protein (ASP) were
identified. Each putative protein sequence was synthe-
sized as overlapping peptide set and was targeted by at
least 2 individuals (range 2–22) of 40 HIV infected sub-
jects tested. HLA-footprint analyses revealed 67 HLA-asso-
ciated imprints (37 gag, 6 nef, 34 pol). For each imprint,
the predicted epitopes were tested in individuals express-
ing the appropriate HLA allele. Several frequently-targeted
antisense epitopes were identified.
Conclusion
CTL responses targeting anti-sense derived epitopes in
HIV may be relatively common and may have an impact
on viral evolution at the population level. Thus, T cell spe-
cificities to anti-sense encoded epitopes may be a biologi-
cally relevant mechanism contributing to immune control
of HIV and may represent interesting vaccine immunogen
candidates.
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